A single nucleotide polymorphism (SNP) change from the UCP3/2 CAD to CAI haplotype led to a significant mean increase in sACE activity of 10·0 nmol his‐leu/ml/min in the T1DM study (P = 0·008). This evidence concerns the gene UCP3 and type 1 diabetes mellitus.